Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy

被引:75
作者
Cuomo, Francesca [1 ]
Altucci, Lucia [1 ]
Cobellis, Gilda [1 ]
机构
[1] Univ Campania L Vanvitelli, Dept Precis Med, Via L De Crecchio 7, I-80138 Naples, Italy
关键词
autophagy; cancer; apoptosis; chloroquine; mTOR inhibitors; drugs; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADVANCED BREAST-CANCER; PHASE-II TRIAL; MTOR INHIBITION; DOUBLE-BLIND; CELL-DEATH; ESTROGEN-RECEPTOR; THYROID-CANCER; ADVANCED NSCLC; DUAL ROLE;
D O I
10.3390/cancers11101465
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Autophagy is a highly conserved catabolic and energy-generating process that facilitates the degradation of damaged organelles or intracellular components, providing cells with components for the synthesis of new ones. Autophagy acts as a quality control system, and has a pro-survival role. The imbalance of this process is associated with apoptosis, which is a "positive" and desired biological choice in some circumstances. Autophagy dysfunction is associated with several diseases, including neurodegenerative disorders, cardiomyopathy, diabetes, liver disease, autoimmune diseases, and cancer. Here, we provide an overview of the regulatory mechanisms underlying autophagy, with a particular focus on cancer and the autophagy-targeting drugs currently approved for use in the treatment of solid and non-solid malignancies.
引用
收藏
页数:24
相关论文
共 141 条
[1]
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases [J].
Al-Bari, Md. Abdul Alim .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) :1608-1621
[2]
Suppressed translation as a mechanism of initiation of CASP8 (caspase 8)-dependent apoptosis in autophagy-deficient NSCLC cells under nutrient limitation [J].
Allavena, Giulia ;
Cuomo, Francesca ;
Baumgartner, Georg ;
Bele, Tadeja ;
Sellgren, Alexander Yarar ;
Oo, Kyaw Soe ;
Johnson, Kaylee ;
Gogvadze, Vladimir ;
Zhivotovsky, Boris ;
Kaminskyy, Vitaliy O. .
AUTOPHAGY, 2018, 14 (02) :252-268
[3]
Lymphoma and Lymphomagenesis in Primary Sjogren's Syndrome [J].
Alunno, Alessia ;
Leone, Maria Comasia ;
Giacomelli, Roberto ;
Gerli, Roberto ;
Carubbi, Francesco .
FRONTIERS IN MEDICINE, 2018, 5
[4]
A Phase 2 Study With a Daily Regimen of the Oral mTOR Inhibitor RAD001 (Everolimus) in Patients With Metastatic Clear Cell Renal Cell Cancer [J].
Amato, Robert J. ;
Jac, Jaroslaw ;
Giessinger, Sarah ;
Saxena, Somyata ;
Willis, James P. .
CANCER, 2009, 115 (11) :2438-2446
[5]
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer [J].
Besse, B. ;
Leighl, N. ;
Bennouna, J. ;
Papadimitrakopoulou, V. A. ;
Blais, N. ;
Traynor, A. M. ;
Soria, J. -C. ;
Gogov, S. ;
Miller, N. ;
Jehl, V. ;
Johnson, B. E. .
ANNALS OF ONCOLOGY, 2014, 25 (02) :409-415
[6]
The Close interconnection between Mitochondrial Dynamics and Mitophagy in Cancer [J].
Bordi, Matteo ;
Nazio, Francesca ;
Campello, Silvia .
FRONTIERS IN ONCOLOGY, 2017, 7
[7]
Autophagy in colorectal cancer: An important switch from physiology to pathology [J].
Burada, Florin ;
Nicoli, Elena Raluca ;
Ciurea, Marius Eugen ;
Uscatu, Daniel Constantin ;
Ioana, Mihai ;
Gheonea, Dan Ionut .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (11) :271-284
[8]
Thyroid cancer [J].
Cabanillas, Maria E. ;
McFadden, David G. ;
Durante, Cosimo .
LANCET, 2016, 388 (10061) :2783-2795
[9]
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer [J].
Carver, Brett S. ;
Chapinski, Caren ;
Wongvipat, John ;
Hieronymus, Haley ;
Chen, Yu ;
Chandarlapaty, Sarat ;
Arora, Vivek K. ;
Le, Carl ;
Koutcher, Jason ;
Scher, Howard ;
Scardino, Peter T. ;
Rosen, Neal ;
Sawyers, Charles L. .
CANCER CELL, 2011, 19 (05) :575-586
[10]
Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy [J].
Chen, Hong-Tao ;
Liu, Hao ;
Mao, Min-Jie ;
Tan, Yuan ;
Mo, Xiang-Qiong ;
Meng, Xiao-Jun ;
Cao, Meng-Ting ;
Zhong, Chu-Yu ;
Liu, Yan ;
Shan, Hong ;
Jiang, Guan-Min .
MOLECULAR CANCER, 2019, 18 (1)